Alkermes (ALKS) Price Target Raised to $41 by Baird Analyst | ALKS Stock News

Author's Avatar
May 02, 2025
Article's Main Image

In recent developments, Baird analyst Joel Beatty has updated his price target for Alkermes (ALKS, Financial), setting a new target of $41.00 USD. This represents an increase from the previous price target of $38.00 USD, reflecting a 7.89% upward revision.

The current rating for Alkermes (ALKS, Financial) by Baird remains "Outperform," consistent with the prior assessment. This indicates ongoing confidence in the company's performance and potential for future growth.

These updates were made public on May 2, 2025, providing investors with the latest insights into Alkermes' market evaluation. The stock continues to be listed on the NASDAQ exchange.

Alkermes (ALKS, Financial), known for its contributions in the biopharmaceutical sector, remains a point of interest for market analysts and investors alike. The adjustment in the price target suggests an optimistic view of the company's future prospects.

Wall Street Analysts Forecast

1918298745234157568.png

Based on the one-year price targets offered by 13 analysts, the average target price for Alkermes PLC (ALKS, Financial) is $39.77 with a high estimate of $52.00 and a low estimate of $30.00. The average target implies an upside of 30.05% from the current price of $30.58. More detailed estimate data can be found on the Alkermes PLC (ALKS) Forecast page.

Based on the consensus recommendation from 15 brokerage firms, Alkermes PLC's (ALKS, Financial) average brokerage recommendation is currently 2.2, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Based on GuruFocus estimates, the estimated GF Value for Alkermes PLC (ALKS, Financial) in one year is $27.53, suggesting a downside of 9.97% from the current price of $30.58. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Alkermes PLC (ALKS) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.